Literature DB >> 22113393

Activity regulation of adenosine deaminases acting on RNA (ADARs).

Cesare Orlandi1, Alessandro Barbon, Sergio Barlati.   

Abstract

Adenosine deaminases acting on RNA (ADARs) are the enzymes that are responsible for the A to I RNA editing process in mammals, which is an important mechanism that increases molecular diversity. A to I RNA editing consists of an enzymatic conversion of specific adenosine in pre-mRNA, leading to alteration of the properties of both the RNA itself and the translated protein. Currently, the importance of this phenomenon is increasingly recognized as it affects a diverse set of cellular pathways. ADAR function within the cell, especially in the neurons, is to diversify the features of a limited set of unique transcripts, mostly neurotransmitter receptors; however, a growing set of target is going to be discovered, increasing the importance of the RNA editing event in the proper physiology of the cell. Despite the functional relevance of these enzymes, there is a gap of knowledge in the mechanisms that regulate ADAR activity and consequently about the modulation of RNA editing process. This review summarizes ongoing investigations of ADAR regulation at the transcriptional, post-transcriptional and post-translational level and addresses new hypothetical mechanisms that are capable of modulating ADAR activity, including subcellular localization, dimerization and interaction with trans-acting factors.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22113393     DOI: 10.1007/s12035-011-8220-2

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  152 in total

1.  Serotonin-2C receptor pre-mRNA editing in rat brain and in vitro by splice site variants of the interferon-inducible double-stranded RNA-specific adenosine deaminase ADAR1.

Authors:  Y Liu; R B Emeson; C E Samuel
Journal:  J Biol Chem       Date:  1999-06-25       Impact factor: 5.157

Review 2.  Adenosine deaminases acting on RNA, RNA editing, and interferon action.

Authors:  Cyril X George; Zhenji Gan; Yong Liu; Charles E Samuel
Journal:  J Interferon Cytokine Res       Date:  2010-12-23       Impact factor: 2.607

Review 3.  A-to-I RNA editing and human disease.

Authors:  Stefan Maas; Yukio Kawahara; Kristen M Tamburro; Kazuko Nishikura
Journal:  RNA Biol       Date:  2006-01-12       Impact factor: 4.652

4.  Dramatic increase of the RNA editing for glutamate receptor subunits during terminal differentiation of clonal human neurons.

Authors:  F Lai; C X Chen; V M Lee; K Nishikura
Journal:  J Neurochem       Date:  1997-07       Impact factor: 5.372

5.  Large-scale proteomics analysis of the human kinome.

Authors:  Felix S Oppermann; Florian Gnad; Jesper V Olsen; Renate Hornberger; Zoltán Greff; György Kéri; Matthias Mann; Henrik Daub
Journal:  Mol Cell Proteomics       Date:  2009-04-15       Impact factor: 5.911

6.  Patterns of developmental expression of the RNA editing enzyme rADAR2.

Authors:  M A O'Connell; A P Gerber; R S Zukin
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

7.  Phylogenetic comparison of the pre-mRNA adenosine deaminase ADAR2 genes and transcripts: conservation and diversity in editing site sequence and alternative splicing patterns.

Authors:  D Slavov; K Gardiner
Journal:  Gene       Date:  2002-10-16       Impact factor: 3.688

Review 8.  Adenosine deaminases acting on RNA (ADARs) are both antiviral and proviral.

Authors:  Charles E Samuel
Journal:  Virology       Date:  2011-01-05       Impact factor: 3.616

Review 9.  Functions and regulation of RNA editing by ADAR deaminases.

Authors:  Kazuko Nishikura
Journal:  Annu Rev Biochem       Date:  2010       Impact factor: 23.643

10.  Down-regulation of RNA editing in pediatric astrocytomas: ADAR2 editing activity inhibits cell migration and proliferation.

Authors:  Caterina Cenci; Rita Barzotti; Federica Galeano; Sandro Corbelli; Rossella Rota; Luca Massimi; Concezio Di Rocco; Mary A O'Connell; Angela Gallo
Journal:  J Biol Chem       Date:  2008-01-04       Impact factor: 5.157

View more
  20 in total

1.  Kainate receptor RNA editing is markedly altered by acute spinal cord injury.

Authors:  Luca Caracciolo; Fabio Fumagalli; Stephana Carelli; Laura Madaschi; Luca La Via; Daniela Bonini; Chiara Fiorentini; Sergio Barlati; Alfredo Gorio; Alessandro Barbon
Journal:  J Mol Neurosci       Date:  2013-08-27       Impact factor: 3.444

2.  The dsRBP and inactive editor ADR-1 utilizes dsRNA binding to regulate A-to-I RNA editing across the C. elegans transcriptome.

Authors:  Michael C Washburn; Boyko Kakaradov; Balaji Sundararaman; Emily Wheeler; Shawn Hoon; Gene W Yeo; Heather A Hundley
Journal:  Cell Rep       Date:  2014-02-06       Impact factor: 9.423

3.  A unique gene expression signature associated with serotonin 2C receptor RNA editing in the prefrontal cortex and altered in suicide.

Authors:  Antonio Fabio Di Narzo; Alexey Kozlenkov; Panos Roussos; Ke Hao; Yasmin Hurd; David A Lewis; Etienne Sibille; Larry J Siever; Eugene Koonin; Stella Dracheva
Journal:  Hum Mol Genet       Date:  2014-04-29       Impact factor: 6.150

4.  Chronic glutamate treatment selectively modulates AMPA RNA editing and ADAR expression and activity in primary cortical neurons.

Authors:  Daniela Bonini; Alice Filippini; Luca La Via; Chiara Fiorentini; Fabio Fumagalli; Marina Colombi; Alessandro Barbon
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

Review 5.  miRNA Editing: New Insights into the Fast Control of Gene Expression in Health and Disease.

Authors:  Jessica Mingardi; Laura Musazzi; Giuseppina De Petro; Alessandro Barbon
Journal:  Mol Neurobiol       Date:  2018-02-19       Impact factor: 5.590

6.  AMPA receptor properties are modulated in the early stages following pilocarpine-induced status epilepticus.

Authors:  Isabella Russo; Daniela Bonini; Luca La Via; Sergio Barlati; Alessandro Barbon
Journal:  Neuromolecular Med       Date:  2013-03-15       Impact factor: 3.843

7.  The Role of ADAR1 and ADAR2 in the Regulation of miRNA-21 in Idiopathic Pulmonary Fibrosis.

Authors:  Gabriela Díaz-Piña; Rosa Ma Ordoñez-Razo; Eduardo Montes; Ignacio Páramo; Carina Becerril; Alfonso Salgado; J Alfredo Santibañez-Salgado; Mariel Maldonado; Victor Ruiz
Journal:  Lung       Date:  2018-04-10       Impact factor: 2.584

8.  Spatio-temporal regulation of ADAR editing during development in porcine neural tissues.

Authors:  Morten T Venø; Jesper B Bramsen; Christian Bendixen; Frank Panitz; Ida Elisabeth Holm; Marie Öhman; Jørgen Kjems
Journal:  RNA Biol       Date:  2012-08-01       Impact factor: 4.652

9.  Modulation of dendritic AMPA receptor mRNA trafficking by RNA splicing and editing.

Authors:  Luca La Via; Daniela Bonini; Isabella Russo; Cesare Orlandi; Sergio Barlati; Alessandro Barbon
Journal:  Nucleic Acids Res       Date:  2012-11-19       Impact factor: 16.971

Review 10.  RNA editing and drug discovery for cancer therapy.

Authors:  Wei-Hsuan Huang; Chao-Neng Tseng; Jen-Yang Tang; Cheng-Hong Yang; Shih-Shin Liang; Hsueh-Wei Chang
Journal:  ScientificWorldJournal       Date:  2013-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.